GlaxoSmithKline Pharmaceuticals is a subsidiary of the GSK Group in India. Its objective is to get ahead of disease with the ...

GSK’s share price has fallen a long way from its one-year high, which has only increased the major undervaluation I'd seen in the stock before that. The post GSK’s share price looks a steal to me ...

In a deal that could potentially be worth up to US$820 million, GlaxoSmithKline (GSK ... and will share up to 50% of net profits on retigabine sales in markets including the US.

In a jobs market marred by a hiring slowdown, Staffline (STAF) appears to be bucking the trend. Unlike its larger peers, the Aim-listed blue-collar recruiter grew revenue, underlying operating profits ...

GSK and ABL Bio have entered into an agreement worth over £2bn to develop new drugs for neurodegenerative ... as well as tiered royalties on future net sales. Christopher Austin, senior vice president ...